Optical Imaging in X-linked Disorders.

NANot yet recruitingINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions
Fragile X Syndrome (FXS)Creatine Transporter Deficiency
Interventions
OTHER

Clinical assessment

Clinical examination including Medical history, developmental trajectory, epilepsy history, ASD symptoms, clinical examination at the inclusion visit by a neuropediatrist

OTHER

Parental questionnaires

Parental questionnaires including Vineland-2, ABC, CBCL, PPD-MRS, SRS-2 and BRIEF completed at the inclusion visit

OTHER

Cognitive assessment

Cognitive assessment including Leiter-3, PPVT 5, EVT 3 completed at the inclusion visit

OTHER

Reasoning assessment

Simple reasoning tasks on tablets performed at the inclusion visit.

DEVICE

fNIRS assessement

Imaging session using fNIRS (NIRSport 8x8, NIRx Medical Technologies LLC, Berlin, Germany) performed at the inclusion visit.

Trial Locations (1)

69500

Woman, mother and child hospital, Hospices Civils de Lyon, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT06868979 - Optical Imaging in X-linked Disorders. | Biotech Hunter | Biotech Hunter